← Back to Search

Procedure

DBS of VIM and PSA for Essential Tremor

N/A
Waitlist Available
Led By Sana Aslam, DO
Research Sponsored by St. Joseph's Hospital and Medical Center, Phoenix
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up following two weeks of treatment at each intervention
Awards & highlights

Study Summary

This trial will study whether stimulating two areas of the brain at once is more effective in treating essential tremor than stimulating just one area.

Eligible Conditions
  • Essential Tremor

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~following two weeks of treatment at each intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and following two weeks of treatment at each intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Stimulation-Induced Balance
Change in Stimulation-Induced Dysarthria
Change in Tremor Phenomenology
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: Group 3Experimental Treatment3 Interventions
Subjects will receive PSA stimulation for two weeks, followed by VIM stimulation for two weeks, and finally VIM+PSA stimulation for two weeks.
Group II: Group 2Experimental Treatment3 Interventions
Subjects will receive VIM+PSA stimulation for two weeks, followed by PSA stimulation for two weeks, and finally VIM stimulation for two weeks.
Group III: Group 1Experimental Treatment3 Interventions
Subjects will receive VIM stimulation for two weeks, followed by VIM+PSA stimulation for two weeks, and finally PSA stimulation for two weeks.

Find a Location

Who is running the clinical trial?

St. Joseph's Hospital and Medical Center, PhoenixLead Sponsor
63 Previous Clinical Trials
14,704 Total Patients Enrolled
2 Trials studying Essential Tremor
5,000 Patients Enrolled for Essential Tremor
Sana Aslam, DOPrincipal InvestigatorSt Josephs Hospital and Medical Center
1 Previous Clinical Trials
11 Total Patients Enrolled

Media Library

PSA Stimulation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05096572 — N/A
Essential Tremor Research Study Groups: Group 3, Group 2, Group 1
Essential Tremor Clinical Trial 2023: PSA Stimulation Highlights & Side Effects. Trial Name: NCT05096572 — N/A
PSA Stimulation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05096572 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers are currently enrolled in this research endeavor?

"Indeed, evidence hosted on clinicaltrials.gov confirms that this medical endeavor is still open for recruitment of participants. The trial was initially posted in November 2021 and has been updated as recently as May 2022 with the aim to recruit 18 individuals at one location."

Answered by AI

Are there currently any vacancies for participants of this experiment?

"The trial is currently open for enrolment and has been since November 2021. Per the latest update, posted on 5th May 2022, clinicaltrials.gov reports that it is actively recruiting participants."

Answered by AI

Who else is applying?

What state do they live in?
Arizona
What site did they apply to?
Barrow Neurological Institite
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

How responsive is this trial?

Typically responds via
Phone Call
Most responsive sites:
  1. Barrow Neurological Institite: < 48 hours
Average response time
  • < 2 Days
~0 spots leftby Apr 2025